Sjögren's Syndrome
Immunology·MeSH: Sjogren's Syndrome
6 drugs in development·6 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| dazodalibep | AMGEN INC (AMGN) |
Phase 2(3)
Phase 1(1)
| Drug | Company |
|---|---|
| vib7734 | Viela Bio, Inc. (VIE) |
Phase 4(1)
| Drug | Company |
|---|---|
| Efgartigimod | ARGENX SE (ARGX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Sjögren's Syndrome?
BioSniper tracks 6 drugs in development for Sjögren's Syndrome across 6 companies.
How many clinical trials target Sjögren's Syndrome?
There are 4 clinical trials targeting Sjögren's Syndrome tracked by BioSniper.
Deep-dive into Sjögren's Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis